FDA Adverse Event Injury Summary report: N

PROCLEIX ULTRIO ELITE ASSAY

MDR report key: 11845122 · Received May 18, 2021

Report

Report Number
2032600-2021-00002
Event Type
Injury
Date Received
May 18, 2021
Date of Event
March 26, 2021
Report Date
May 18, 2021
Manufacturer
GRFIOLS DIAGNOSTIC SOLUTIONS INC.
Product Code
QHO
PMA / PMN Number
BL125652
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

ON (B)(6) 2021, GRIFOLS CUSTOMER QUALTEX LABS ((B)(6) REPORTED A PROCLEIX ULTRIO ELITE ASSAY NONREACTIVE, HIV SEROLOGY POSITIVE RESULT IN A SERUM SAMPLE. PLASMA FROM THE SAME DONOR WAS RETESTED IN DUPLICATE WITH THE PROCLEIX ULTRIO ELITE ASSAY AND WAS REACTIVE IN BOTH REPLICATES. THE PLASMA SAMPLE WAS ALSO TESTED WITH THE PROCLEIX HIV DISCRIMINATORY ASSAY (DHIV) AND WAS HIV REACTIVE. THE CUSTOMER RELEASED RESULTS AS ULTRIO ELITE REACTIVE, DHIV REACTIVE AND THE SAMPLE WAS DISCARDED. NO VOLUME REMAINS FOR INVESTIGATION AND NO DONOR HISTORY WAS AVAILABLE. A PREVIOUS EVENTS SEARCH SHOWED ONE OTHER COMPLAINT (B)(4) FOR ULTRIO ELITE FALSE NEGATIVE OVER THE PRIOR YEAR. THE ROOT CAUSE WAS DETERMINED TO BE LOW TITER SAMPLE. THE REAGENT QC RELEASE DATA WAS REVIEWED AND THERE WERE NO INDICATIONS OF A PROBLEM WITH HIV SENSITIVITY. MASTER LOT 703154 PASSED ALL SENSITIVITY SPECIFICATIONS FOR HIV-1 AND HIV-2, IN ADDITION TO ALL OTHER ANALYTES AND SPECIFICATIONS. WITHOUT REMAINING SAMPLE VOLUME FOR INVESTIGATION, ROOT CAUSE COULD NOT BE DETERMINED. BASED ON THE PREVIOUS EVENTS SEARCH AND THE REVIEW OF THE MASTER LOT RELEASE DATA, THE MOST LIKELY ROOT CAUSE IS LOW TITER HIV. NO FURTHER INFORMATION IS EXPECTED, THIS IS CONSIDERED THE FINAL REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
738516 PROCLEIX ULTRIO ELITE ASSAY HIV-1/HIV-2/HCV/HBV DEVICE QHO GRFIOLS DIAGNOSTIC SOLUTIONS INC. 703154

Patients

Seq Age Sex Outcome Treatment
1 Other